In response to an Ebola outbreak, the U.S. has banned entry for foreign travelers who have been in the Democratic Republic of the Congo, Uganda, or South Sudan in the…
Vetenskapsnyheter
The rejection may make the pharma firms remaining lawsuits more difficult.
The question of whether to partner with Chinese firms — or see them as rivals — is tearing biotech apart, pitting peers and partners against one another
Americans exposed to Ebola outbreak, Bill Cassidy's primary defeat, and more health news from Morning Rounds
China's ascent is forcing U.S. biotech companies and investors to pick a side: Is it an ally or an existential threat?
Jesse Goodman, former director of CBER and former FDA chief scientist, calls for five critical changes to restore trust in the Advisory Committee on Immunization Practices.
Opinion: Vaccine policy it is not a matter of autonomy at all, because infants do not decline vaccination — their parents do.
A pair of advocacy groups is threatening legal action unless the U.K. government revokes regulations at the heart of a new pharma trade agreement with the U.S.
A number of Americans who are in the Congo are believed to have had exposure to suspected cases in the country’s latest Ebola outbreak, sources have told STAT.
When should you get a mammogram? Conflicting advice makes it hard to know.
The deadly outbreak of a rare strain of hantavirus on a cruise has generated echoes of the pandemic era, including conspiracy theories.
Key health lawmaker Sen. Bill Cassidy will lose his seat, as Louisiana’s Senate primary heads for a runoff between state treasurer John Fleming and Trump-backed Rep. Julia Letlow.
The WHO said an Ebola outbreak first seen in the Democratic Republic of the Congo was an international public health emergency, underscoring the world's concerns.
Bill Cassidy, leader of the Senate committee that oversees health policy, is fighting for his political life in Louisiana's Republican primary on Saturday.
“There's been interest in longevity, promoting it, for millennia. But this 25-year campaign really brought it to the forefront,” Eric Topol says of blue zones.
“The norm-shattering masks a more fundamental misunderstanding of how administrative power can bring about lasting change,” writes Joshua Sharfstein.
The acting director of the FDA’s drug center, Tracy Beth Høeg, is leaving the agency. The news come days after Commissioner Marty Makary handed in his resignation.
Takeda Pharmaceuticals agreed to pay $13.6 million to settle allegations that it paid kickbacks to doctors to prescribe an antidepressant.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
“Preparedness is not built during a crisis press conference or after a pathogen has already crossed borders,” writes Krutika Kuppalli.
A new Ebola outbreak has been confirmed in Congo’s remote Ituri province, with 246 suspected cases and 65 deaths recorded so far.
Makary and Cassidy's fates, U.S. pressures Germany to pay more for drugs, and other health news
In today's Pharmalittle roundup: U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and much more.
Restricting telehealth prescribing of mifepristone wouldn't spell the end of telehealth medication abortion, writes OB-GYN Christine Henneberg.
Africa CDC declares Ebola outbreak in DRC, the violent fallout from Trump’s cuts to foreign aid, and more health news